Tear‐Based Biomarker Trajectories Associated With Uveitis in Juvenile Idiopathic Arthritis: A Multicenter Prospective Study

Ilaria Macorra, Mariia Pavlenko, Mekibib Altaye, Hermine I. Brunner, John Bohnsack, Margaret H. Chang, Ashley M. Cooper, Stefanie Davidson, Alexandra Duell, Bharti Gangwani, Aimee Hersh, Gary N. Holland, Carl D. Langefeld, Melissa Lerman, Mindy Lo, Virginia Miraldi Utz, Sampath Prahalad, Grant Schulert, Alyssa Sproles, Megan Quinlan‐Waters, Erin Stahl, Sherry Thornton, Edmund Tsui, Sheila T. Angeles‐Han
Arthritis Care and Research · Wiley · 2026-11-11 · DOI: 10.1002/acr.80192

Abstract

Objective The extent of uveitis risk in juvenile idiopathic arthritis (JIA) is based on clinical factors. We aim to compare the trajectories of tear‐based biomarker levels of patients with JIA with and without uveitis. Methods This prospective multicenter study included children with JIA at risk for uveitis (JIA‐no‐U) and those with JIA‐associated uveitis (JIA‐U). Serial tear samples were collected from each eye by Schirmer strips at enrollment and the first and second follow‐up visits (FU1 and FU2). S100 proteins, cytokines, and chemokines were assayed by Luminex or enzyme‐linked immunosorbent assay and compared between groups. Results Fifty patients (37 JIA‐no‐U, 13 JIA‐U) contributed 222 samples (150 JIA‐no‐U, 73 JIA‐U). At enrollment, there were no significant differences in biomarker levels between JIA‐U and JIA‐no‐U. During follow‐up of patients with JIA‐U, monocyte chemoattractant protein 1 (MCP‐1) levels increased longitudinally from enrollment to FU1 and FU2 (LS mean ± SE 1.63 ± 0.31 to 2.46 ± 0.31, P = 0.005; and 2.89 ± 0.32, P < 0.0001), and there was a similar increase in CXCL10 (LS mean ± SE 4.39 ± 0.41 to 5.26 ± 0.41, P = 0.030; and 6.51 ± 0.43, P < 0.0001) and interleukin‐8 (IL‐8) levels from enrollment to FU1 and FU2 (LS mean ± SE 3.09 ± 0.30 to 4.25 ± 0.30, P = 0.006; and 4.65 ± 0.32, P ≤ 0.001). In both groups, S100A12 and S100A8/A9 levels increased from enrollment to follow‐up. Conclusion Longitudinal changes in MCP‐1, CXCL10, and IL‐8 levels in tear fluid in JIA‐U may reflect inflammatory ocular processes and support the role of monocytes and interferon‐related pathways in uveitis. Lack of differences in S100 proteins may reflect systemic inflammation from arthritis. Tear‐based biomarkers may support clinical factors for identifying children with JIA who develop uveitis.

Read at publisher →

Similar articles